Influenza type A virus: An outstandingly protean pathogen and a potent modular weapon

Critical Reviews in Microbiology

Volumn 39, Issue 2, 2013, Pages 123-138

  Shoham, Dany ^a  

^a BAR ILAN UNIVERSITY   (Israel)

Author keywords

Biological warfare agents; Dual use biotechnologies; Epizootic strains; Induced epidemicity; Influenza A; Pandemic strains

Indexed keywords

ANTHRAX TOXIN; OUTER MEMBRANE PROTEIN F;

ANTIGENICITY; BIOLOGICAL WARFARE; BIOLOGICAL WARFARE AGENT; BIOSAFETY; ENDEMIC DISEASE; EPIDEMIC; EXPERIMENTAL INFECTION; GENETIC ENGINEERING; GENETIC MANIPULATION; GENETIC REASSORTMENT; HERD IMMUNITY; HOST RANGE; HUMAN; HUMAN ACTIVITIES; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; INFLUENZA VIRUS A H3N8; INFLUENZA VIRUS A H5N1; INFLUENZA VIRUS A H7N2; INFLUENZA VIRUS A H7N3; INFLUENZA VIRUS A H7N7; INFLUENZA VIRUS A H9N2; INTELLIGENCE; IRAN; LARGE SCALE PRODUCTION; LETHALITY; MORTALITY; NONHUMAN; NORTH KOREA; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROPHYLAXIS; PROTECTION; REVERSE GENETICS; REVIEW; RISK ASSESSMENT; SPONTANEOUS MUTATION; THREAT; VACCINATION; VIRUS CULTURE; VIRUS DETECTION; VIRUS MUTANT; VIRUS MUTATION; VIRUS PATHOGENESIS; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS VIRULENCE; WATER CONTAMINATION; WEAPON;

ANIMALS; BIOTERRORISM; HUMANS; INFLUENZA A VIRUS; INFLUENZA, HUMAN; ORTHOMYXOVIRIDAE INFECTIONS;

AVES; INFLUENZA A VIRUS; PROTEA;

EID: 84875921109     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2012.692355     Document Type: Review

References (96)

1. Greninger A. (2004). The Defnition and Measurement of Dangerous Research, www.cissm.umd.edu/papers/fles/greninger.pdf
2. Altmüller A, Kunerl M, Müller K, Hinshaw VS, Fitch WM, Scholtissek C. (1992). Genetic relatedness of the nucleoprotein (NP) of recent swine, turkey, and human infuenza A virus (H1N1) isolates. Virus Res, 22, 79-87.
3. Anchlan D, Ludwig S, Nymadawa P, Mendsaikhan J, Scholtissek C. (1996). Previous H1N1 infuenza A viruses circulating in the Mongolian population. Arch Virol, 141, 1553-1569.
4. Beare AS, Webster RG. (1991). Replication of avian infuenza viruses in humans. Arch Virol, 119, 37-42.
5. Both GW, Shi CH, Kilbourne ED. (1983). Hemagglutinin of swine infuenza virus: a single amino acid change pleiotropically afects viral antigenicity and replication. Proc Natl Acad Sci USA, 80, 6996-7000.
6. Buxton Bridges C, Katz JM, Seto WH, Chan PK, Tsang D, Ho W, Mak KH, Lim W, Tam JS, Clarke M, Williams SG, Mounts AW, Bresee JS, Conn LA, Rowe T, Hu-Primmer J, Abernathy RA, Lu X, Cox NJ, Fukuda K. (2000). Risk of infuenza A (H5N1) infection among health care workers exposed to patients with infuenza A (H5N1), Hong Kong. J Infect Dis, 181, 344-348.
7. Carrat F, Vergu E, Ferguson NM, Lemaitre M, Cauchemez S, Leach S, Valleron AJ. (2008). Time lines of infection and disease in human infuenza: a review of volunteer challenge studies. Am J Epidemiol, 167, 775-785.
8. CBS 60 Minutes. Swine Flu. June 19, 2009.
9. Chen PS, Tsai FT, Lin CK, Yang CY, Chan CC, Young CY, Lee CH. (2010). Ambient infuenza and avian infuenza virus during dust storm days and background days. Environ Health Perspect, 118, 1211-1216.
10. Cohen J. (2012). The Limits of Avian Flu Studies in Ferrets. Science, 335, 512-513.
11. Copeland KM, Elliot AJ, Daniels RS. (2005). Functional chimeras of human immunodefciency virus type 1 Gp120 and infuenza A virus (H3) hemagglutinin. J Virol, 79, 6459-6471.
12. Enserink M. (2012). Scientists Brace for Media Storm Around Controversial Flu Studies. Science. http://news.sciencemag.org/scienceinsider/2011/11/ scientists-brace-for-media-storm.html. Retrieved 2012-01-23.
13. European labs discover fu vaccines contaminated, March 28, 2009 Flu News Network http://cottontopssandbox. wordpress.com/2009/03/28/european-labs- discover-fu-vaccines-contaminated
14. Flandorfer A, García-Sastre A, Basler CF, Palese P. (2003). Chimeric infuenza A viruses with a functional infuenza B virus neuraminidase or hemagglutinin. J Virol, 77, 9116-9123.
15. Flint M, Tomas JM, Maidens CM, Shotton C, Levy S, Barclay WS, McKeating JA. (1999). Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol, 73, 6782-6790.
16. Fouchier RAM, Schneeberger PM, Rozendaal FM, et al. (2004). Avian infuenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome. Proceedings of the National Academy of Sciences USA, 101, 1356-1361.
17. Gaydos JC, Top FH, Hodder RA, Russell PK. (2006). Swine infuenza A outbreak, Fort Dix, New Jersey, 1976. Emerging Infectious Diseases, 12, 23-28.
18. Ghedin E, Fitch A, Boyne A, Griesemer S, DePasse J, Bera J, Zhang X, Halpin RA, Smit M, Jennings L, St George K, Holmes EC, Spiro DJ. (2009). Mixed infection and the genesis of infuenza virus diversity. J Virol, 83, 8832-8841.
19. Gibbs AJ, Armstrong JS, Downie JC. (2009). From where did the 2009 'swine-origin' infuenza A virus (H1N1) emerge? Virol J, 6, 207.
20. Gilbert M, Xiao X, Domenech J, Lubroth J, Martin V, Slingenbergh J. (2006). Anatidae migration in the western Palearctic and spread of highly pathogenic avian infuenza H5NI virus. Emerging Infect Dis, 12, 1650-1656.
21. Goldfeld M, Bartley JD, Pizzuti W, et al. (1977). Infuenza in New Jersey in 1976: isolations of infuenza A/New Jersey/76 at Fort Dix. J Infectious Diseases, 136, S347-S355.
22. Harmon K. (2011). What Will the Next Infuenza Pandemic Look Like?. Scientifc American. http://www.scientifcamerican.com/article.cfm?id=next- infuenza-pandemic. Retrieved 2012-01-23.
23. Harris S. 1991 Japanese biological warfare experiments and other atrocities in Manchuria, 1932-1945, and the subsequent United States cover up: a preliminary assessment, Crime, Law and Social Change, Volume 15, Number 3/1991 http://www.springerlink.com/content/x8k1r31367450677/
24. Hatziioannou T, Valsesia-Wittmann S, Russell SJ, Cosset FL. (1998). Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses. J Virol, 72, 5313-5317.
25. Hayden FG, Jennings L, Robson R, Schif G, Jackson H, Rana B, McClelland G, Ipe D, Roberts N, Ward P. (2000). Oral oseltamivir in human experimental infuenza B infection. Antivir Ter (Lond), 5, 205-213.
26. Helen B. Canadian intelligence report about the weaponization of bird fu declassifed, The Canadian Press, March 8, 2005.
27. How to Deal with Swine Flu: Heeding the Mistakes of 1976, TIME Magazine, Apr. 27, 2009.
28. Hugh-Jones ME, Rosenberg BH, Jacobsen S. (2011). The 2001 anthrax attack: Key observations. Journal of Bioterrorism & Biodefense, Special Issue 3, http://dx.doi.org/10.4172/2157-2526.S3-001
29. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. (2012). Experimental adaptation of an infuenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets, Nature doi:10.1038/nature10831 http://www.nature.com/nature/journal/ vaop/ncurrent/full/nature10831.html
30. Infuenza Overview-ProMED Summary of Strains, 2004 http://www. medicalecology.org/diseases/infuenza/infuenza.htm Iran to produce bird fu vaccine, A P. Jan 16, 2008.
31. Jackson BA et al. (2006). Bioterrorism with Zoonotic Disease: Public Health Preparedness Lessons from a Multiagency Exercise, Biosecurity and Bioterrorism: Biodefence Strategy. Practice and Science, 4.
32. Kasel JA, Couch RB. (1969). Experimental infection in man and horses with infuenza A viruses. Bull World Health Organ, 41, 447-452.
33. Kendal AP, Noble GR, Dowdle WR. (1977). Swine infuenza viruses isolated in 1976 from man and pig contain two coexisting subpopulations with antigenically distinguishable hemagglutinins. Virology, 82, 111-121.
34. Khalenkov A, Perk S, Panshin A, Golender N, Webster RG. (2009). Modulation of the severity of highly pathogenic H5N1 infuenza in chickens previously inoculated with Israeli H9N2 infuenza viruses. Virology, 383, 32-38.
35. Kobasa D, Jones SM, Shinya K, et al. (2007). Aberrant innate immune response in lethal infection of macaques with the 1918 infuenza virus. Nature, 445, 319-323.
36. Koebler J. Universal Flu Vaccine Could Be Available by 2013 U.S. News January 13, 2012.
37. Krug RM. (2003). The potential use of infuenza virus as an agent for bioterrorism. Antiviral Res, 57, 147-150.
38. Langley WA et al. (2010). Induction of Neutralizing Antibody Responses to Anthrax Protective Antigen by Using Infuenza Virus Vectors: Implications for Disparate Immune System Priming Pathways. Journal of Virology, 84, 8300-8307.
39. Lazarovits J, Naim HY, Rodriguez AC, Wang RH, Fire E, Bird C, Henis YI, Roth MG. (1996). Endocytosis of chimeric infuenza virus hemagglutinin proteins that lack a cytoplasmic recognition feature for coated pits. J Cell Biol, 134, 339-348.
40. Lee YJ, Choi YK, Kim YJ, et al. (2008). Highly pathogenic avian infuenza virus (H5N1) in domestic poultry and relationship with migratory birds, South Korea. Emerging Infectious Diseases, 14, 487-490.
41. Li KS, Guan Y, Wang J, Smith GJ, Xu KM, Duan L, Rahardjo AP, Puthavathana P, Buranathai C, Nguyen TD, Estoepangestie AT, Chaisingh A, Auewarakul P, Long HT, Hanh NT, Webby RJ, Poon LL, Chen H, Shortridge KF, Yuen KY, Webster RG, Peiris JS. (2004). Genesis of a highly pathogenic and potentially pandemic H5N1 infuenza virus in eastern Asia. Nature, 430, 209-213.
42. Lipsitch M, Riley S, Cauchemez S, Ghani AC, Ferguson NM. (2009). Managing and reducing uncertainty in an emerging infuenza pandemic. N Engl J Med, 361, 112-115.
43. MacKenzie D., Bioterror fears could block crucial fu research New Scientist, 21 November 2011, http://www.newscientist.com/article/dn21195- bioterror-fears-could-block-crucial-fu-research.html
44. Madjid M, Scott L, Parsa M, Ward C. (2003). Infuenza as a bioweapon. J Royal Soc Med, 96, 345-346.
45. Marisa P et al. (2009). Avian infuenza vaccination in Egypt: Limitations of the current Strategy. J Mol Genet Med, 3, 198-204.
46. Martin HR, Zambon ACRM, Barclay WS. (2004). Restrictions to the adaptation of infuenza A virus H5 hemagglutinin to the human host. J Virol, 78, 502-507.
47. Mitzi B. Grant will fund study of infuenza as agent of bioterror, Stanford Report, September 24, 2003.
48. Observer: Bird fu crimes? February 20, 2008.
49. Ogata T, Yamazaki Y, Okabe N, Nakamura Y, Tashiro M, Nagata N, Itamura S, Yasui Y, Nakashima K, Doi M, Izumi Y, Fujieda T, Yamato S, Kawada Y. (2008). Human H5N2 avian infuenza infection in Japan and the factors associated with high H5N2-neutralizing antibody titer. J Epidemiol, 18, 160-166.
50. Oliveira BC, Liberto MI, Barth OM, Cabral MC. (2002). Construction of yellow fever-infuenza A chimeric virus particles. J Virol Methods, 106, 185-196.
51. Ozawa Y, Makino S, Park JY, Chang JH, Kim JH, An SH. (2006). A review of recent unexpected animal disease events in Japan and Korea and the follow-up action taken. Rev-Of Int Epizoot, 25, 125-135.
52. Oxford J. (2004). Nature's biological weapon. Nature, 429, 345-346.
53. Pandemic Infuenza Civil-Military Senior Planners Workshop, US-Pacifc-Command notifcation, April 11, 2010 http://us-pacifc-command. blogspot.com/2010/04/us-and-laos-co-host-multinational.html
54. Pantin-Jackwood M, Wasilenko JL, Spackman E, Suarez DL, Swayne DE. (2010). Susceptibility of turkeys to pandemic-H1N1 virus by reproductive tract insemination. Virol J, 7, 27.
55. Pattie DC. Avian infuenza as a biological weapon: Treat assessment and public health alert, Ph.D. Tesis, 2008, George Mason University, Virginia.
56. Peterson AT, Benz BW, Papes M. (2007). Highly pathogenic H5N1 avian infuenza: entry pathways into North America via bird migration. PLoS ONE, 2, e261.
57. Q&A: Siti Fadilah Supari. Nature News. Nature Publishing Group. 2007-12-09. http://www.nature.com/news/2007/071219/full/4501137a.html
58. Racaniello V. (2012). Infuenza H5N1 is not lethal in ferrets after airborne transmission, Virology Blog, March 2012 http://www. virology.ws/2012/03/01/infuenza-h5n1-is-not-lethal-in-ferrets-after-airborne- transmission/.
59. Reid AH, Fanning TG, Hultin J V, Taubenberger JK. (1999). Origin and evolution of the 1918 "Spanish" infuenza virus hemagglutinin gene. Proceedings of the National Academy of Sciences USA, 96, 1651-1656.
60. Reid AH, Fanning TG, Janczewski TA, Taubenberger JK. (2000). Characterization of the 1918 "Spanish" infuenza virus neuraminidase gene. Proceedings of the National Academy of Sciences USA, 97, 6785-6790.
61. Rose E. Labs urged to destroy pandemic fu strain. Associated Press, London, UK, 12 April 2005.
62. Schafer FL, Soergel ME, Straube DC. (1976). Survival of airborne infuenza virus: efects of propagating host, relative humidity, and composition of spray fuids. Arch Virol, 51, 263-273.
63. Schijven FJ, Teunis PFM, Roda Husman AM. Quantitative Risk Assessment of Avian Infuenza Virus Infection via Water, 1-Mar-2006, Rijksinstituut voor Volksgezondheid en Milieu RIVM, http://hdl.handle.net/10029/7430
64. Schoch-Spana M. (2000). Implications of pandemic infuenza for bioterrorism response. Clin Infect Dis, 31, 1409-1413.
65. Sharshov K, Silko N, Sousloparov I, Zaykovskaya A, Shestopalov A, Drozdov I. (2010). Avian infuenza (H5N1) outbreak among wild birds, Russia, 2009. Emerging Infect Dis, 16, 349-351.
66. Shoham D, Wolfson Z. (2004). The Russian biological weapons program: vanished or disappeared? Crit Rev Microbiol, 30, 241-261.
67. Shoham D. (2005a). Image versus reality of Iranian chemical and biological weapons. International J. of Intelligence and Counterintelligence, 18, 89-141.
68. Shoham D. (2005b). Viral Pathogens of Humans Likely to be Preserved in Natural Ice. In: Life in Ancient Ice (ed. Castello JD and Rogers SO), Princeton University Press, Princeton, pp. 208-226.
69. Shoham D. (2006). Review: molecular evolution and the feasibility of an avian infuenza virus becoming a pandemic strain-a conceptual shift. Virus Genes, 33, 127-132.
70. Shoham D, Rogers SO. (2006). Greenland as a plausible springboard for trans-Atlantic avian infuenza spread. Med Hypotheses, 67, 1460-1461.
71. Shoham D. (2007a). Bioterrorism In: Handbook of Pharmaceutical Biotechnology, John Wiley and Sons, Editor-in-Chief: Shayne Gad, pp. 1525-1651.
72. Shoham D. (2007b). How will Iran retaliate to a strike on its nuclear facilities? Contemporary Security Policy, 28, 542-558.
73. Shoham D, Jacobsen S. (2007). Technical intelligence in retrospect: the 2001 anthrax letters powder. International J. of Intelligence and Counterintelligence, 20, 79-105.
74. Shoham D. (2009). Is there a Critical Mass that would likely trigger the Emergence of a Pandemic Avian Infuenza Genotype? In: Viral Genomes: Diversity, Properties and Parameters Editors: Zhi Feng and Ming Long, Nova Science Publishers, Inc. pp. 123-143.
75. Shoham D. (2011). The Modes of Evolutionary Emergence of Primal and Late Pandemic Infuenza Virus Strains from Viral Reservoir in Animals: An Interdisciplinary Analysis, Infuenza Research and Treatment, vol. 2011, Article ID 861792, 27 pages. doi:10.1155/2011/861792 Infuenza Research and Treatment, http://www.hindawi.com/journals/irt/2011/861792/.
76. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma SK, Cheung CL, Raghwani J, Bhatt S, Peiris JS, Guan Y, Rambaut A. (2009). Origins and evolutionary genomics of the 2009 swine-origin H1N1 infuenza A epidemic. Nature, 459, 1122-1125.
77. Sorrell EM, Wan H, Araya Y, Song H, Perez DR. (2009). Minimal molecular constraints for respiratory droplet transmission of an avian-human H9N2 infuenza A virus. Proc Natl Acad Sci USA, 106, 7565-7570.
78. Srinivasan A, Viswanathan K, Raman R, et al. (2008). Quantitative biochemical rationale for diferences in transmissibility of 1918 pandemic infuenza A viruses. Proceedings of the National Academy of Sciences USA, 105, 2800-2805.
79. Staczek J, Gilleland HE Jr, Gilleland LB, Harty RN, García-Sastre A, Engelhardt OG, Palese P. (1998). A chimeric infuenza virus expressing an epitope of outer membrane protein F of Pseudomonas aeruginosa afords protection against challenge with P. aeruginosa in a murine model of chronic pulmonary infection. Infect Immun, 66, 3990-3994.
80. Stephen E, Gary M, Greg G, Jim G, Mike W. ProPublica, Was the FBI's Science Good Enough to ID the Anthrax Killer? Scientifc American, October 11, 2011 www.scientifcamerican.com/article.cfm?id=fbi-science-good-enough-id- anthrax-killer
81. Stewart JJ. (2002). Parameters of Infuenza Aerosol Transmission. Comments on Teoretical Biology, 7, 445-457.
82. Symons H. (2002). Report on Royal Society and British Association for the Advancement of Science Meeting on Bioterrorism, December 2001, UK.
83. Tellier R. (2006). Review of aerosol transmission of infuenza A virus. Emerging Infect Dis, 12, 1657-1662.
84. The Fourth ESWI http://www.eswiconference.org Infuenza Conference 11-14 September 2011 Malta.
85. Tomas G. (2006). North Korea weaponizing bird fu-Bio-warfare experts call it 'greatest threat al-Qaida could unleash. Joseph Farah's G2 Bulletin Top Story, London.
86. Tumpey TM, Maines TR, Van Hoeven N, et al. (2007). A Two-Amino Acid Change in the Hemagglutinin of the 1918 A Infuenza Virus Abolishes Transmission. Science, 315, 655-659.
87. Update on Avian Infuenza-OIE www.oie.int/../AVIAN%20 INFLUENZA/A-AI-Asia. htm
88. US Department of Homeland Security and Health and Human Services' pandemic fu web site: www.pandemicfu.gov. Vector Website-http://www.vector.nsc. ru/DesktopDefault.aspx?lcid= 9&tabindex=1&tabid=52
89. Von Bubnof A. (2005). Special Report: The 1918 fu virus is resurrected. Nature, 437, 794-795.
90. Vorobev AA. (2001). Evaluation of probability of use of bioagents as biological weapons. Epidemiol. Infektsion Bolez, 6, 54-56.
91. When politics and swine fu infect health, Stephanie Beck, SF Gate, April 30, 2009.
92. WHO concerned that new H5N1 infuenza research could undermine the 2011. Pandemic Infuenza Preparedness Framework; Statement-30 December 2011 http://www.who.int/mediacentre/news/statements/2011/pip-framework-20111229/en/ index.html
93. WHO Memorandum-Missing samples of deadly fu strain, 19 April 2005.
94. WHO. Inter-country-consultation: infuenza A/H5N1 in humans in Asia: Manila, Philippines. http://www.who.int/csr/resources/publications/influenza/ WHO-CDS-CSR-GIP-2005-7/en/2005.
95. Wintemitz MC, Wason IM, McNamara FP. (1920). The Pathology of Infuenza. New Haven, CT, Yale University Press.
96. Zimmer SM, Burke DS. (2009). Historical perspective-Emergence of infuenza A (H1N1) viruses. N Engl J Med, 361, 279-285.